Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 229055

CYTOKINE PROFILE AND ITS INFLUENCE TO ACR INDEX IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB


Novak, Srđan; Anić, Branimir; Čikeš, Nada; Bosnic, Dubravka; Sentić, Mirna; Budiselic, R;
CYTOKINE PROFILE AND ITS INFLUENCE TO ACR INDEX IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB // Ann Rheum Dis 2005 ; 64(Suppl III):451
Beč, Austrija: BMJ Publishing Group, 2005. (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 229055 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
CYTOKINE PROFILE AND ITS INFLUENCE TO ACR INDEX IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB

Autori
Novak, Srđan ; Anić, Branimir ; Čikeš, Nada ; Bosnic, Dubravka ; Sentić, Mirna ; Budiselic, R ;

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Ann Rheum Dis 2005 ; 64(Suppl III):451 / - : BMJ Publishing Group, 2005

Skup
Annual European Congress of Rheumatology, EULAR 2005

Mjesto i datum
Beč, Austrija, 8.-11.6.2005

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
infliximab; cytokines; disease activity

Sažetak
Background: During infliximab treatment in rheumatoid arthritis (RA) patients, inhibition of TNF alfa and consequently the changes in levels of other cytokines occurs. Objectives: To evaluate changes of IL-6, sTNFR and IL-10 during infliximab and methotrexate (MTX)treatment in the period of 62 weeks and correlate their values with ACR index. Methods: 24 patients with active RA despite therapy with MTX were treated with infliximab in dosage of 3 mg/kg in weeks 0, 2, 6 and then every 8 weeks until week 54. All patients were on MTX. ACR index was calculated in week 0, 6, 30 and 62. ESR, CRP, IL-6, sTNFR and IL-10 were measured in weeks 2, 4, 6, 14, 30, 54 and 62. Results: Already after the first application of infliximab levels of CRP (p=0.0004), IL-6 (p=0.000002) and sTNFR (p=0.00003) significantly reduced, and statistically significant difference was maintained until week 62. There were no statistically significant changes in values of IL-10. Comparing values of IL-6 with ACR index, non-responders were found to have levels of IL-6 significantly higher(p=0.037) than responders. However, values of sTNFR in comparison with ACR index have not shown statistically significant changes (p=0.12). Conclusion: Treatment with infliximab leads to reduction of IL-6 and sTNFR after the first application of the drug. Values of IL-6 correlate well with ACR index while values of sTNFR do not differ in responders and non-responders to infliximab.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
0108190

Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb

Profili:

Avatar Url Branimir Anić (autor)

Avatar Url Srđan Novak (autor)

Avatar Url Mirna Sentić (autor)


Citiraj ovu publikaciju

Novak, Srđan; Anić, Branimir; Čikeš, Nada; Bosnic, Dubravka; Sentić, Mirna; Budiselic, R;
CYTOKINE PROFILE AND ITS INFLUENCE TO ACR INDEX IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB // Ann Rheum Dis 2005 ; 64(Suppl III):451
Beč, Austrija: BMJ Publishing Group, 2005. (poster, međunarodna recenzija, sažetak, znanstveni)
Novak, S., Anić, B., Čikeš, N., Bosnic, D., Sentić, M., Budiselic, R. & (2005) CYTOKINE PROFILE AND ITS INFLUENCE TO ACR INDEX IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB. U: Ann Rheum Dis 2005 ; 64(Suppl III):451.
@article{article, year = {2005}, pages = {451}, keywords = {infliximab, cytokines, disease activity}, title = {CYTOKINE PROFILE AND ITS INFLUENCE TO ACR INDEX IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB}, keyword = {infliximab, cytokines, disease activity}, publisher = {BMJ Publishing Group}, publisherplace = {Be\v{c}, Austrija} }
@article{article, year = {2005}, pages = {451}, keywords = {infliximab, cytokines, disease activity}, title = {CYTOKINE PROFILE AND ITS INFLUENCE TO ACR INDEX IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB}, keyword = {infliximab, cytokines, disease activity}, publisher = {BMJ Publishing Group}, publisherplace = {Be\v{c}, Austrija} }




Contrast
Increase Font
Decrease Font
Dyslexic Font